The NIH FY12 Appropriation: What Do We Know So Far?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

Now that we finally know (more or less) what the budget situation will be for the remainder of FY11, we must turn our attention to the odious task of following the FY12 appropriation saga as it unfolds. Where do we stand so far on the FY12 Appropriation Bill?

NIH has requested $31.987B for FY12. Last February, the Administration endorsed that request, recommending $31.829B  for the agency. (For those keeping score at home, the Administration’s FY12 request for NSF was $7.424B and for DOE’s Office of Science they recommended $5.4B.) The Administration’s NIH request is 3.4% over the FY10 enacted level, though when adjusted for inflation that amount represents approximately level funding.

Earlier this month, the Republican-controlled House of Representatives released their version of the FY12 budget, which bears not even a fleeting resemblance to the one proposed by the Administration. Their budget includes drastic cuts across the board, including to the Department of Defense, as Republicans begin to craft their message of financial restraint for the 2012 Presidential election. Their goal is to cut discretionary spending to pre-2008 levels and freeze it there for five years, as they seek to tackle the alarming federal budget deficit (there are 12 zeros in $15 trillion, in case you were wondering). The Democratic Senate and the Administration are almost certain to reject the austere proposal, thus setting the stage for another budget drama in which the two chambers of Congress cannot come to agreement on the FY12 Appropriations bill. For an excellent overview of the House FY12 budget proposal, click here.

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter